Q2 2026 Acme United Corp Earnings Call Transcript
Key Points
- Acme United Corp (ACU) reported a 16% increase in net sales, rising from $54 million to $63 million.
- Net income increased from $4.8 million to $5.1 million, with earnings per share up 5% to $1.22.
- The acquisition of MyMedic has contributed positively, with sales of approximately $4.3 million in the second quarter.
- Gross margins improved from 41% to 42.6%, driven by high-margin MyMedic products.
- Strong performance in core businesses, with a 10% increase in U.S. first aid and medical product sales and an 8% increase in Westcott Cutting Tools sales.
- The company faces challenges from a global macroeconomic environment, including high inflation and interest rates.
- Supply chain disruptions and high tariffs have impacted gross margins, particularly in the U.S., where margins declined by approximately 100 basis points.
- SG&A expenses increased significantly, from $15.8 million to $19.9 million, primarily due to MyMedic's high advertising costs.
- Net debt increased from $22.8 million to $27.3 million, partly due to the acquisition of MyMedic.
- Year-to-date net income decreased by 6%, largely due to the impact of higher tariffs in the first quarter.
Good day, and welcome to the ACME United Second Quarter 2026 Financial Results Conference Call.
At this time, I'd like to turn the call over to your host, Walter Johnson, Chairman and CEO. Please go ahead, sir.
Good morning. Welcome to the second quarter 2026 earnings conference call for ACME United Corporation.
I am Walter C. Johnson, Chairman and CEO.
With me is Paul Driscoll, our Chief Financial Officer, who will first read a safe harbor statement. Paul.
Forward-looking statements in this conference call, including without limitation statements related to the company's plans, strategies, objectives, expectations, intentions, and adequacy of capital and other resources, are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1,995.
Investors are cautioned
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
